VYNE Therapeutics
VYNE
VYNE
58 hedge funds and large institutions have $110M invested in VYNE Therapeutics in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $139M → $110M (-$29.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.75M | |
| 2 | +$1.69M | |
| 3 | +$455K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$388K |
| 5 |
Renaissance Technologies
New York
|
+$374K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$394K | |
| 3 | -$306K | |
| 4 |
Morgan Stanley
New York
|
-$209K |
| 5 |
First Manhattan
New York
|
-$184K |